Bernadette Ferraro
15Patents
2h-index
24Co-inventors
50Inventor score
Filing activity: Nov 2, 2010 → Aug 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8927692B2 | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same | Emerging Cross-Sectional Technologies | 9 | Active |
| US9399056B2 | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same | Emerging Cross-Sectional Technologies | 3 | Active |
| US9109014B2 | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom | Physics | 2 | Active |
| US9913885B2 | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same | Emerging Cross-Sectional Technologies | 2 | Active |
| US11045535B2 | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same | Emerging Cross-Sectional Technologies | 1 | Active |
| US11684659B2 | Tumor cell vaccines | Human Necessities | 0 | Active |
| US12049479B2 | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom | Physics | 0 | Active |
| US10799572B2 | Consensus antigen constructs and vaccines made therefrom, and methods of using the same to treat malaria | Emerging Cross-Sectional Technologies | 0 | Active |
| US12109258B2 | Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US9669091B2 | Vaccines having an antigen and interleukin-23 as an adjuvant | Emerging Cross-Sectional Technologies | 0 | Active |
| US11124545B2 | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom | Physics | 0 | Active |
| US11369668B1 | Tumor cell vaccines | Human Necessities | 0 | Active |
| US11980659B2 | Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same | Emerging Cross-Sectional Technologies | 0 | Active |
| US10294278B2 | Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom | Physics | 0 | Active |
| US12350318B2 | Combination therapy to treat brain cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.